Browse by Title

Type here to filter the list

S
Safety Monitoring of BNT162b2 (Pfizer-BioNTech) COVID-19 Vaccines in U.S. Children aged 5-17 years

Mao Hu – Acumen, LLC ### 1655532###Co-Author######Acumen, LLC###
Co-Author: Mao Hu – Acumen, LLC
### @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Co-Author###Associate Director for Science###US Food and Drug Administration###
Co-Author: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Yuhui Feng, MS – Acumen LLC ### 1991518###Co-Author######Acumen LLC###
Co-Author: Yuhui Feng, MS – Acumen LLC
### @@@ Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration ### 1655306###Presenting Author###Health Statistician###US Food and Drug Administration###
Presenting Author: Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration
### @@@ Elizabeth R. Smith – Acumen, LLC ### 1659094###Co-Author######Acumen, LLC###
Co-Author: Elizabeth R. Smith – Acumen, LLC
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###
Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
### @@@ Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research ### 1062536###Co-Author###Sr. Director, Safety & Epidemiology###Carelon Research###
Co-Author: Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research
### he/him/his @@@ Joann F. Gruber, PhD (she/her/hers) – US Food and Drug Administration ### 1991147###Co-Author###Epidemiologist###US Food and Drug Administration###
Co-Author: Joann F. Gruber, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Mahasweta Mitra, MPH – Acumen,LLC ### 1991405###Co-Author###Data and Policy Analyst###Acumen,LLC###
Co-Author: Mahasweta Mitra, MPH – Acumen,LLC
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology ### 1046832###Co-Author###Chief Scientific Officer###Optum Epidemiology###
Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
### @@@ Alex Secora, PhD – IQVIA ### 1991253###Co-Author######IQVIA###
Co-Author: Alex Secora, PhD – IQVIA
### @@@ Joyce Obidi, PhD – US. Food and Drug Administration ### 1358853###Co-Author###Health Scientist###US. Food and Drug Administration###
Co-Author: Joyce Obidi, PhD – US. Food and Drug Administration
### @@@ Jing Wang – Acumen, LLC ### 1991406###Co-Author######Acumen, LLC###
Co-Author: Jing Wang – Acumen, LLC
### @@@ Jennifer Song, MA, MURP – Optum Epidemiology ### 1360471###Co-Author###Senior Epidemiology Analyst###Optum Epidemiology###
Co-Author: Jennifer Song, MA, MURP – Optum Epidemiology
### @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health Clinical Trial Services ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health Clinical Trial Services###
Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health Clinical Trial Services
### @@@ Djeneba Audrey Djibo, PhD – CVS Health ### 1655293###Co-Author###Lead Director - Epidemiology###CVS Health###
Co-Author: Djeneba Audrey Djibo, PhD – CVS Health
### @@@ Rowan McEvoy, B.S. – Acumen, LLC ### 1991408###Co-Author######Acumen, LLC###
Co-Author: Rowan McEvoy, B.S. – Acumen, LLC
### @@@ Rose Do – Acumen, LLC ### 1991326###Co-Author######Acumen, LLC###
Co-Author: Rose Do – Acumen, LLC
### @@@ Yoganand Chillarige, MPA – Acumen, LLC ### 1655508###Co-Author###Research Manager###Acumen, LLC###
Co-Author: Yoganand Chillarige, MPA – Acumen, LLC
### @@@ Robin Clifford, MS – Optum Epidemiology ### 1358796###Co-Author######Optum Epidemiology###
Co-Author: Robin Clifford, MS – Optum Epidemiology
### @@@ Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration ### 1358855###Co-Author###Associate Director Post-market Surveillance###US Food and Drug Administration###
Co-Author: Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration
### @@@ Richard A. Forshee, PhD – FDA/CBER ### 1358508###Co-Author###Deputy Director###FDA/CBER###
Co-Author: Richard A. Forshee, PhD – FDA/CBER
### @@@ Steven A. Anderson, PhD – FDA/CBER ### 1358532###Co-Author######FDA/CBER###
Co-Author: Steven A. Anderson, PhD – FDA/CBER
###
Safety in Numbers: A Potpourri

Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité ### 1062567###Co-Moderator###Associate Professor###Institute of Clinical Pharmacology and Toxicology, Charité###
Co-Moderator: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité
### he/him/his @@@ Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062583###Co-Moderator###Senior scientist###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Co-Moderator: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers
Safety of concomitant administration of 23-valent polysaccharide pneumococcal vaccine and influenza vaccine among the elderly

Heehyun Won, MS – Department of Health Convergence, College of Science and Industry Convergence, Ewha Womans University, Seoul, Republic of Korea ### 1358470###Presenting Author###PhD student###Department of Health Convergence, College of Science and Industry Convergence, Ewha Womans University, Seoul, Republic of Korea###
Presenting Author: Heehyun Won, MS – Department of Health Convergence, College of Science and Industry Convergence, Ewha Womans University, Seoul, Republic of Korea
### @@@ Jeong Ah Kim – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea ### 1991667###Co-Author######Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea###
Co-Author: Jeong Ah Kim – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea
### @@@ Na-Young Jeong, MS – Department of Health Convergence, Ewha Womans University ### 1062838###Co-Author###Ph.D. student###Department of Health Convergence, Ewha Womans University###
Co-Author: Na-Young Jeong, MS – Department of Health Convergence, Ewha Womans University
### @@@ Nam-Kyong Choi – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea ### 1660178###Co-Author######Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea###
Co-Author: Nam-Kyong Choi – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea
###
Safety of COVID-19 mRNA Vaccination among Young Children in the Vaccine Safety Datalink

Kristin S. Goddard, MPH (she/her/hers) – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California ### 1655534###Presenting Author###Research Manager###Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California###
Presenting Author: Kristin S. Goddard, MPH (she/her/hers) – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California
### she/her/hers @@@ James G. Donahue, DVM, PhD – Marshfield Clinic Research Institute ### 1655536###Co-Author######Marshfield Clinic Research Institute###
Co-Author: James G. Donahue, DVM, PhD – Marshfield Clinic Research Institute
### @@@ Ned Lewis, MPH – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California ### 1655535###Co-Author###Data Manager###Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California###
Co-Author: Ned Lewis, MPH – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California
### @@@ Kayla E. Hanson, MPH – Marshfield Clinic Research Institute ### 1655763###Co-Author######Marshfield Clinic Research Institute###
Co-Author: Kayla E. Hanson, MPH – Marshfield Clinic Research Institute
### @@@ Bruce Fireman – kaiser ### 1655762###Co-Author###Biostatistician###kaiser###
Co-Author: Bruce Fireman – kaiser
### @@@ Nicola P. Klein, MD, PhD – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California ### 1062961###Co-Author######Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California###
Co-Author: Nicola P. Klein, MD, PhD – Kaiser Permanente Vaccine Study Center - Kaiser Permanente Northern California
###
Scaling-up Real-World Evidence Generation for Regulators in Europe: DARWIN EU

Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Lead Speaker###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###
Lead Speaker: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University ### 1092267###Speaker###Associate Professor###Department of Medical Informatics, Erasmus MC University###
Speaker: Katia M. Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC University
### she/her/hers @@@ Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358374###Speaker###Senior Researcher###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Speaker: Edward Burn, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency ### 1062632###Speaker###Senior Clinical Epidemiologist###European Medicines Agency###
Speaker: Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency
### @@@ Andrej Segec, MPharm MSc (he/him/his) – European Medicines Agency ### 1658869###Speaker###Scientific administrator###European Medicines Agency###
Speaker: Andrej Segec, MPharm MSc (he/him/his) – European Medicines Agency
### he/him/his @@@ Patrick B. Ryan, PhD – Johnson & Johnson ### 1661016###Speaker######Johnson & Johnson###
Speaker: Patrick B. Ryan, PhD – Johnson & Johnson
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Speaker###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###
Speaker: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center ### 1094832###Speaker###Professor Medical Informatics###Department of Medical Informatics, Erasmus University Medical Center###
Speaker: Peter R. Rijnbeek, PhD – Department of Medical Informatics, Erasmus University Medical Center
### @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Speaker###Head of Real World Evidence###European Medicines Agency###
Speaker: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Gianmario Candore, MSc – Bayer AG ### 1659477###Speaker###Partnerships Senior Manager###Bayer AG###
Speaker: Gianmario Candore, MSc – Bayer AG
###
Sclerostin inhibition, cardiovascular biomarkers, risk factors, and clinical outcomes: a Mendelian randomisation analysis using UK Biobank data

Marta Alcalde-Herraiz – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1991479###Presenting Author###Research assistant###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Presenting Author: Marta Alcalde-Herraiz – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358612###Co-Author###DPhil Candidate & Research Assistant###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Co-Author: Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Danielle Newby, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1991362###Co-Author###Postdoctoral researcher###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Co-Author: Danielle Newby, PhD – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Clara Prats, PHD (she/her/hers) – Universitat Politècnica de Catalunya ### 1358939###Co-Author###Professor and Researcher###Universitat Politècnica de Catalunya###
Co-Author: Clara Prats, PHD (she/her/hers) – Universitat Politècnica de Catalunya
### she/her/hers @@@ Dipender Gill – Imperial College London ### 1655602###Co-Author######Imperial College London###
Co-Author: Dipender Gill – Imperial College London
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###
Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1360474###Co-Author###Senior Researcher in Public Health and Epidemiology###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Co-Author: Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1659148###Co-Author###Senior Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Co-Author: Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### he/him/his
Self-Controlled and Other Methods Stuff

Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1062523###Co-Moderator###Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###
Co-Moderator: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Hiraku Kumamaru, MD, ScD – Graduate School of Medicine, The University of Tokyo ### 1658910###Co-Moderator###Associate Professor###Graduate School of Medicine, The University of Tokyo###
Co-Moderator: Hiraku Kumamaru, MD, ScD – Graduate School of Medicine, The University of Tokyo
###
Sequential Safety Monitoring of Rofecoxib for Cardiovascular Adverse Effects

Saad Hanif Abbasi, PhD. student – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark ### 1991459###Presenting Author###PhD. student###Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark###
Presenting Author: Saad Hanif Abbasi, PhD. student – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark
### @@@ Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062545###Co-Author###Postdoctoral researcher###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###
Co-Author: Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
### he/him/his @@@ Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark ### 1062967###Co-Author###Professor of clinical pharmacology###University of Southern Denmark###
Co-Author: Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark
### he/him/his @@@ Martin Thomsen Ernst – University of Southern Denmark ### 1358301###Co-Author######University of Southern Denmark###
Co-Author: Martin Thomsen Ernst – University of Southern Denmark
### @@@ Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062518###Co-Author###Professor###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###
Co-Author: Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
###
Severity Score Extraction from Clinical Notes Using Natural Language Processing: Applications to Dermatology

Vikas Kumar, MD, MS – OMNY Health ### 1359577###Presenting Author###Sr Data Scientist###OMNY Health###
Presenting Author: Vikas Kumar, MD, MS – OMNY Health
### @@@ Lawrence Rasouliyan, MPH – OMNY Health ### 1359580###Co-Author###Head, Biostatistics & Data Science###OMNY Health###
Co-Author: Lawrence Rasouliyan, MPH – OMNY Health
### @@@ Amanda G. Althoff, MS – OMNY Health ### 1659852###Co-Author###Senior Data Scientist###OMNY Health###
Co-Author: Amanda G. Althoff, MS – OMNY Health
### @@@ Stella Chang, MPH – OMNY Health ### 1991733###Co-Author###Senior Vice President, Customer Success###OMNY Health###
Co-Author: Stella Chang, MPH – OMNY Health
### @@@ Stacey Long, MS – OMNY Health ### 1359578###Co-Author###Chief Strategy Officer###OMNY Health###
Co-Author: Stacey Long, MS – OMNY Health
###
SGLT2 Inhibitors Associated with Decreased Risk of Nephrolithiasis Compared to GLP-1 Receptor Agonists: An Active Comparator, New User Cohort Study

Adrian Martinez-De la Torre, PhD – Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland ### 1063022###Presenting Author###Research Associate###Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland###
Presenting Author: Adrian Martinez-De la Torre, PhD – Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
### @@@ Andrea M. Burden, PhD – Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland ### 1358409###Co-Author###Assistant Professor###Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland###
Co-Author: Andrea M. Burden, PhD – Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland
### @@@ Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062518###Co-Author###Professor###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###
Co-Author: Anton Pottegård, PhD, MSc – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
### @@@ Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062545###Co-Author###Postdoctoral researcher###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###
Co-Author: Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
### he/him/his
Sharing is Caring? A Symposium on Code Sharing in Pharmacoepidemiology

Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT ### 1360173###Lead Speaker###Assistant Professor###London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT###
Lead Speaker: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT
### @@@ John R. Tazare, PhD – London School of Hygiene and Tropical Medicine ### 1062669###Speaker###Assistant Professor###London School of Hygiene and Tropical Medicine###
Speaker: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine
### @@@ Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency ### 1647043###Speaker###Head of Epidemiology###Medicines and Healthcare products Regulatory Agency###
Speaker: Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency
### @@@ Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1046819###Speaker###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###
Speaker: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### he/him/his @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Speaker###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London ### 1358165###Speaker###Professor###London School of Hygiene & Tropical Medicine, London###
Speaker: Ian Douglas, PhD – London School of Hygiene & Tropical Medicine, London
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Speaker###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###
Speaker: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School ### 1062580###Speaker###Associate Professor###Brigham and Women's Hospital, Harvard Medical School###
Speaker: Shirley V. Wang, PhD, FISPE (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Caroline Morton, MRCGP MSc BMedSci MbChb – Queen Mary University of London ### 1991556###Speaker###Senior Clinical Research Fellow###Queen Mary University of London###
Speaker: Caroline Morton, MRCGP MSc BMedSci MbChb – Queen Mary University of London
### @@@ Jennifer R. Popovic, DVM – GSK ### 1991567###Speaker###Senior Director###GSK###
Speaker: Jennifer R. Popovic, DVM – GSK
### @@@ Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency ### 1062632###Speaker###Senior Clinical Epidemiologist###European Medicines Agency###
Speaker: Daniel R. Morales, MBChB, BMSc, PhD, MRCP, MRCGP – European Medicines Agency
###
Short-Term Effectiveness of Bivalent COVID-19 mRNA Booster Vaccinations in the Veterans Health Administration Using Self-Controlled Risk Interval and Test-Negative Case-Control Designs

Caroline Korves, ScD (she/her/hers) – White River Junction Veterans Affairs Medical Center, White River Junction, VT ### 1991421###Presenting Author###Epidemiologist###White River Junction Veterans Affairs Medical Center, White River Junction, VT###
Presenting Author: Caroline Korves, ScD (she/her/hers) – White River Junction Veterans Affairs Medical Center, White River Junction, VT
### she/her/hers @@@ Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA ### 1659297###Co-Author###Associate Director ###Office of Vaccines Research and Review, CBER/FDA###
Co-Author: Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA
### @@@ Abirami S. Balajee, MPH – White River Junction Veterans Affairs Medical Center, White River Junction, VT ### 1991423###Co-Author######White River Junction Veterans Affairs Medical Center, White River Junction, VT###
Co-Author: Abirami S. Balajee, MPH – White River Junction Veterans Affairs Medical Center, White River Junction, VT
### @@@ Gabrielle M. Zwain, BA – White River Junction Veterans Affairs Medical Center, White River Junction, VT ### 1991424###Co-Author######White River Junction Veterans Affairs Medical Center, White River Junction, VT###
Co-Author: Gabrielle M. Zwain, BA – White River Junction Veterans Affairs Medical Center, White River Junction, VT
### @@@ Jeremy Smith, MS – White River Junction Veterans Affairs Medical Center, White River Junction, VT ### 1991425###Co-Author######White River Junction Veterans Affairs Medical Center, White River Junction, VT###
Co-Author: Jeremy Smith, MS – White River Junction Veterans Affairs Medical Center, White River Junction, VT
### @@@ David J. Graham, MD, MPH – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1655356###Co-Author###Associate director###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###
Co-Author: David J. Graham, MD, MPH – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Yinong Young-Xu, ScD, MS, MA – Veterans Affairs Medical Center, White River Junction, VT, USA ### 1659630###Co-Author###Director, Clinical Epidemiology Program###Veterans Affairs Medical Center, White River Junction, VT, USA###
Co-Author: Yinong Young-Xu, ScD, MS, MA – Veterans Affairs Medical Center, White River Junction, VT, USA
###
Sickle Cell Disease Acute Event Frequencies in the United States – A Retrospective Cohort Study Using Optum Electronic Health Records

Xunming Sun, PhD (she/her/hers) – Pfizer Inc. ### 1991438###Presenting Author###Postdoctoral Research Fellow, Epidemiology Scientist###Pfizer Inc.###
Presenting Author: Xunming Sun, PhD (she/her/hers) – Pfizer Inc.
### she/her/hers @@@ Yun Gu, PhD – Pfizer Inc. at the time of this work ### 1991439###Co-Author######Pfizer Inc. at the time of this work###
Co-Author: Yun Gu, PhD – Pfizer Inc. at the time of this work
### @@@ Steven Arkin, MD – Pfizer Inc. ### 1655415###Co-Author###Vice-President Rare Hematology Clinical Research###Pfizer Inc.###
Co-Author: Steven Arkin, MD – Pfizer Inc.
### @@@ Stephen E. Schachterle, PhD – Pfizer Inc. ### 1657348###Co-Author###Senior Director###Pfizer Inc.###
Co-Author: Stephen E. Schachterle, PhD – Pfizer Inc.
### @@@ Xiaofeng Zhou, PhD – Pfizer Inc ### 1062976###Co-Author###Sr. Director###Pfizer Inc###
Co-Author: Xiaofeng Zhou, PhD – Pfizer Inc
### @@@ Thomas Edwards, MS – Panalgo Inc. ### 1991440###Co-Author######Panalgo Inc.###
Co-Author: Thomas Edwards, MS – Panalgo Inc.
### @@@ Shannon Marraffino, MD – Pfizer Inc. ### 1991441###Co-Author######Pfizer Inc.###
Co-Author: Shannon Marraffino, MD – Pfizer Inc.
###
Signal detection using longitudinal healthcare claims data; a pilot study using Lantus as case drug

Lockwood Taylor, PhD – IQVIA ### 1657985###Presenting Author###Senior Principal###IQVIA###
Presenting Author: Lockwood Taylor, PhD – IQVIA
### @@@ Marie-Laure Kürzinger, MSc – Sanofi ### 1657665###Co-Author######Sanofi###
Co-Author: Marie-Laure Kürzinger, MSc – Sanofi
### @@@ Ruben Hermans, PhD – IQVIA ### 1991623###Co-Author######IQVIA###
Co-Author: Ruben Hermans, PhD – IQVIA
### @@@ Bernadette Dwan, BSc MPHARM MPSI – IQVIA ### 1991624###Co-Author###Product Strategy lead###IQVIA###
Co-Author: Bernadette Dwan, BSc MPHARM MPSI – IQVIA
### @@@ Priyanka Chhikara, Rph, MBA – Sanofi ### 1991625###Co-Author######Sanofi###
Co-Author: Priyanka Chhikara, Rph, MBA – Sanofi
### @@@ Xinyu Li – Sanofi Inc ### 1991626###Co-Author######Sanofi Inc###
Co-Author: Xinyu Li – Sanofi Inc
### @@@ Sreenivas Thummisetti, MBBS, Ph.D – Sanofi ### 1991627###Co-Author###Global Safety Officer, Sanofi###Sanofi###
Co-Author: Sreenivas Thummisetti, MBBS, Ph.D – Sanofi
### @@@ Sandrine Colas, PhD – Sanofi ### 1991628###Co-Author###Pharmacoepidemiologist###Sanofi###
Co-Author: Sandrine Colas, PhD – Sanofi
### @@@ Marielle Duverne, n/a – sanofi ### 1991629###Co-Author###Pharmacovigilance Scientist###sanofi###
Co-Author: Marielle Duverne, n/a – sanofi
### @@@ Juhaeri Juhaeri, PhD – Epidemiology & Benefit - Risk Evaluation, Sanofi ### 1094012###Co-Author###VP and Global Head###Epidemiology & Benefit - Risk Evaluation, Sanofi###
Co-Author: Juhaeri Juhaeri, PhD – Epidemiology & Benefit - Risk Evaluation, Sanofi
###
Signal Evaluation Using Observational Databases to Examine Methylphenidate Use and the Risk of Epistaxis

David M. Kern, PhD, MS – Janssen Research & Development ### 1062834###Presenting Author###Sr. Director, Epidemiology###Janssen Research & Development###
Presenting Author: David M. Kern, PhD, MS – Janssen Research & Development
### @@@ Steven S. Smugar – Janssen R&D ### 1991370###Co-Author######Janssen R&D###
Co-Author: Steven S. Smugar – Janssen R&D
### @@@ Azza Shoaibi, PhD, MPH – Janssen Research & Development ### 1360292###Co-Author###Associate director ###Janssen Research & Development###
Co-Author: Azza Shoaibi, PhD, MPH – Janssen Research & Development
### @@@ Patrina Muller, RN, MPH &TM – Janssen R&D ### 1991372###Co-Author###Manager Safety Analysis Scientist###Janssen R&D###
Co-Author: Patrina Muller, RN, MPH &TM – Janssen R&D
### @@@ Anthony G. Sena, BA – Janssen R&D ### 1360294###Co-Author###Director - Observational Health Data Analytics###Janssen R&D###
Co-Author: Anthony G. Sena, BA – Janssen R&D
### @@@ Martijn Schuemie – Janssen R&D ### 1657738###Co-Author######Janssen R&D###
Co-Author: Martijn Schuemie – Janssen R&D
### @@@ James P. Gilbert, PhD – Janssen Research & Development ### 1659757###Co-Author###Manager of Epidemiology Analytics###Janssen Research & Development###
Co-Author: James P. Gilbert, PhD – Janssen Research & Development
### @@@ Mitchell M. Conover, PhD – Janssen R&D ### 1658363###Co-Author###Associate Director, Observational Health Data Analytics###Janssen R&D###
Co-Author: Mitchell M. Conover, PhD – Janssen R&D
### @@@ Patrick B. Ryan, PhD – Johnson & Johnson ### 1661016###Co-Author######Johnson & Johnson###
Co-Author: Patrick B. Ryan, PhD – Johnson & Johnson
###
Socioeconomic position and adherence to adjuvant endocrine therapy in premenopausal breast cancer patients – a Danish population-based cohort study

Julie A. Schmidt, MSc, DPhil (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1655695###Presenting Author###Postdoc###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Presenting Author: Julie A. Schmidt, MSc, DPhil (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### she/her/hers @@@ Kirsten M. Woolpert – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1661021###Co-Author###PhD Student###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Co-Author: Kirsten M. Woolpert – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Cathrine F. Hjorth – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1657893###Co-Author###MSPH, PhD###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Co-Author: Cathrine F. Hjorth – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Dóra K. Farkas – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1659144###Co-Author######Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Co-Author: Dóra K. Farkas – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Bent Ejlertsen, MD, DMSc, PhD – Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark ### 1358744###Co-Author######Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark###
Co-Author: Bent Ejlertsen, MD, DMSc, PhD – Department of Oncology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
### @@@ Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1359288###Co-Author###Professor & Chair###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Deirdre P. Cronin-Fenton, PhD (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1358742###Co-Author###Associate Professor###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Co-Author: Deirdre P. Cronin-Fenton, PhD (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### she/her/hers
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Fractures in Postmenopausal Women with Type 2 Diabetes: A Nationwide Cohort Study

Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University ### 1991617###Presenting Author###PhD student###School of Pharmacy, Sungkyunkwan University###
Presenting Author: Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University
### @@@ Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1358246###Co-Author###Doctoral student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University ### 1062594###Co-Author###Postdoctoral Research Fellow###Sungkyunkwan University###
Co-Author: Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University
### he/him/his @@@ Sohee Park, PharmD, PhD – UCL School of Pharmacy ### 1302811###Co-Author######UCL School of Pharmacy###
Co-Author: Sohee Park, PharmD, PhD – UCL School of Pharmacy
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Hepatocellular Carcinoma Among Patients with Type 2 Diabetes: A Population-Based Cohort Study

Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1358246###Presenting Author###Doctoral student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University ### 1062594###Co-Author###Postdoctoral Research Fellow###Sungkyunkwan University###
Co-Author: Han Eol Jeong, MPH, PhD (he/him/his) – Sungkyunkwan University
### he/him/his @@@ Yunha Noh, PharmD, PhD – McGill University ### 1062651###Co-Author######McGill University###
Co-Author: Yunha Noh, PharmD, PhD – McGill University
### @@@ Sohee Park, PharmD, PhD – UCL School of Pharmacy ### 1302811###Co-Author######UCL School of Pharmacy###
Co-Author: Sohee Park, PharmD, PhD – UCL School of Pharmacy
### @@@ Dong Hyun Sinn, MD, PhD – Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ### 1991737###Co-Author######Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea###
Co-Author: Dong Hyun Sinn, MD, PhD – Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
### @@@ Jae Hyeon Kim, MD, PhD – Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea ### 1991599###Co-Author######Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea###
Co-Author: Jae Hyeon Kim, MD, PhD – Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
### @@@ Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada ### 1358432###Co-Author###Assistant Professor###Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada###
Co-Author: Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada
### @@@ Laurent Azoulay, PhD – McGill University ### 1302855###Co-Author###Associate Professor###McGill University###
Co-Author: Laurent Azoulay, PhD – McGill University
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Sodium-Glucose Cotransporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists, and the Risk of Macrovascular, and Microvascular Complications Among Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1358246###Presenting Author###Doctoral student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Presenting Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Kristian B. Filion, PhD (he/him/his) – McGill University ### 1062622###Co-Author###Associate Professor###McGill University###
Co-Author: Kristian B. Filion, PhD (he/him/his) – McGill University
### he/him/his @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Standardization over disease risk score versus propensity score for confounding control when using random forests for model fitting

Yi Li, MS (she/her/hers) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University ### 1991515###Presenting Author###PhD student###Department of Epidemiology, Biostatistics and Occupational Health, McGill University###
Presenting Author: Yi Li, MS (she/her/hers) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University
### she/her/hers @@@ Tibor Schuster, PhD – Department of Family Medicine, McGill University ### 1093618###Co-Author######Department of Family Medicine, McGill University###
Co-Author: Tibor Schuster, PhD – Department of Family Medicine, McGill University
### @@@ Kazuki Yoshida, MD, MPH, ScD – OM1, Inc. ### 1991516###Co-Author######OM1, Inc.###
Co-Author: Kazuki Yoshida, MD, MPH, ScD – OM1, Inc.
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Co-Author###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###
Co-Author: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his
Statin use and the risk of cancer in patients with heart failure: a target trial emulation

Chengsheng Ju, MPharm (he/him/his) – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom ### 1991171###Presenting Author###PhD Researcher###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom###
Presenting Author: Chengsheng Ju, MPharm (he/him/his) – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
### he/him/his @@@ Wallis Lau, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK ### 1063024###Co-Author######Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK###
Co-Author: Wallis Lau, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK
### @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom###
Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
###
Statins may modulate the effectiveness of the flu vaccine according to the type of respiratory outcome: Results from the Statin Treatment OPtions during vaccination against inFLUenza (STOPFlu) study

William Henley – University of Exeter ### 1659798###Presenting Author######University of Exeter###
Presenting Author: William Henley – University of Exeter
### @@@ Adam J. Streeter, PhD – University of Munster, Germany ### 1660053###Co-Author###Biostatistician###University of Munster, Germany###
Co-Author: Adam J. Streeter, PhD – University of Munster, Germany
###
Statistical Outlier Detection to Identify Uncoded High-Dose Case Reports in VigiBase for Medication Error Signals

Alem Zekarias – Uppsala Monitoring Centre ### 1991660###Co-Author######Uppsala Monitoring Centre###
Co-Author: Alem Zekarias – Uppsala Monitoring Centre
### @@@ Eva-Lisa Meldau, MSc – Uppsala Monitoring Centre ### 1077343###Presenting Author###Senior Data Scientist###Uppsala Monitoring Centre###
Presenting Author: Eva-Lisa Meldau, MSc – Uppsala Monitoring Centre
### @@@ Sara Hedfors Vidlin – Uppsala Monitoring Centre ### 1358944###Co-Author###Data Scientist###Uppsala Monitoring Centre###
Co-Author: Sara Hedfors Vidlin – Uppsala Monitoring Centre
### @@@ Ingrid Lönnstedt – Uppsala Monitoring Centre ### 1991663###Co-Author######Uppsala Monitoring Centre###
Co-Author: Ingrid Lönnstedt – Uppsala Monitoring Centre
### @@@ Ghita Benabdallah, PharmD – Centre Anti Poison et de Pharmacovigilance du Maroc - RCC ### 1991664###Co-Author###Pharmacist###Centre Anti Poison et de Pharmacovigilance du Maroc - RCC###
Co-Author: Ghita Benabdallah, PharmD – Centre Anti Poison et de Pharmacovigilance du Maroc - RCC
### @@@ Loubna Alj, PharmD – Centre Anti Poison et de Pharmacovigilance du Maroc ### 1991665###Co-Author###Pharmacist Epidemiologist###Centre Anti Poison et de Pharmacovigilance du Maroc###
Co-Author: Loubna Alj, PharmD – Centre Anti Poison et de Pharmacovigilance du Maroc
### @@@ Houda Sefiani, MD, Phd – Centre anti poison et de pharmacovigilance du Maroc-RCC ### 1991666###Co-Author######Centre anti poison et de pharmacovigilance du Maroc-RCC###
Co-Author: Houda Sefiani, MD, Phd – Centre anti poison et de pharmacovigilance du Maroc-RCC
###
Stroke, Myocardial Infarction, and Pulmonary Embolism after COVID-19 mRNA bivalent booster in People Aged 50 Years or Older

Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE (ANSM/CNAM) ### 1360145###Presenting Author###Epidemiologist###EPI-PHARE (ANSM/CNAM)###
Presenting Author: Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE (ANSM/CNAM)
### @@@ Marion Bertrand – EPI-PHARE (ANSM/CNAM) ### 1359610###Co-Author###MSc###EPI-PHARE (ANSM/CNAM)###
Co-Author: Marion Bertrand – EPI-PHARE (ANSM/CNAM)
### @@@ Jérémie Botton, PhD, PharmD, MPH (he/him/his) – EPI-PHARE ### 1360499###Co-Author###PhD, PharmD, MPH###EPI-PHARE###
Co-Author: Jérémie Botton, PhD, PharmD, MPH (he/him/his) – EPI-PHARE
### he/him/his @@@ Stéphane Le Vu – EPI-PHARE (ANSM/CNAM) ### 1655649###Co-Author######EPI-PHARE (ANSM/CNAM)###
Co-Author: Stéphane Le Vu – EPI-PHARE (ANSM/CNAM)
### @@@ Jérôme Drouin – EPI-PHARE (ANSM/CNAM) ### 1360500###Co-Author######EPI-PHARE (ANSM/CNAM)###
Co-Author: Jérôme Drouin – EPI-PHARE (ANSM/CNAM)
### @@@ Alain Weill – EPI-PHARE ### 1358499###Co-Author######EPI-PHARE###
Co-Author: Alain Weill – EPI-PHARE
### @@@ Rosemary Dray-Spira – EPI-PHARE ### 1093512###Co-Author######EPI-PHARE###
Co-Author: Rosemary Dray-Spira – EPI-PHARE
### @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE###
Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE
###
Structural Racism and Inequities in Real-World Treatment and Survival Among Patients with Four Solid-Tumor Cancers

Harlan R. Pittell, PhD (he/him/his) – Flatiron Health ### 1655521###Presenting Author###Quantitative Scientist###Flatiron Health###
Presenting Author: Harlan R. Pittell, PhD (he/him/his) – Flatiron Health
### he/him/his @@@ Jenny Guadamuz, PhD – Flatiron Health ### 1655497###Co-Author###Senior Health Equity Scientist###Flatiron Health###
Co-Author: Jenny Guadamuz, PhD – Flatiron Health
### @@@ Amy Pierre, MSN, ANP-BC – Flatiron Health ### 1655504###Co-Author######Flatiron Health###
Co-Author: Amy Pierre, MSN, ANP-BC – Flatiron Health
### @@@ Cleo Ryals, PhD – Flatiron Health ### 1991178###Co-Author###Head of Health Equity###Flatiron Health###
Co-Author: Cleo Ryals, PhD – Flatiron Health
### @@@ Gregory S. Calip, PharmD, MPH, PhD (he/him/his) – University of Southern California ### 1655507###Co-Author###Adjunct Associate Professor###University of Southern California###
Co-Author: Gregory S. Calip, PharmD, MPH, PhD (he/him/his) – University of Southern California
### he/him/his
Sustainable Drug Use: Role of Pharmacoepidemiologists and Their Tools Addressing Environmental Impact of Drug Utilization

Björn Wettermark, MscPharm, PhD (he/him/his) – Uppsala university ### 1358174###Lead Speaker###Professor###Uppsala university###
Lead Speaker: Björn Wettermark, MscPharm, PhD (he/him/his) – Uppsala university
### he/him/his @@@ Ana Tomas, MD, PhD – Faculty or Medicine, University of Novi Sad ### 1658321###Speaker###Assistant Professor###Faculty or Medicine, University of Novi Sad###
Speaker: Ana Tomas, MD, PhD – Faculty or Medicine, University of Novi Sad
### @@@ Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ ### 1302720###Speaker###Professor of Medicine and Epidemiology###Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ###
Speaker: Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
### @@@ Johanna Villén, MSc – Uppsala University ### 1991120###Speaker###PhD student###Uppsala University###
Speaker: Johanna Villén, MSc – Uppsala University
###